Suchergebnisse - "Marra, Fiona"

PubPharm (45)

1

Prevalence of Potentially Clinically Significant Drug-Drug Interactions With Antiretrovirals Against HIV Over Three Decades : A Systematic Review of the Literature

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Hodge, D. | Hodel, E. | Hughes, E. | +8

2

The Collaborative Care Model : Realizing healthcare values and increasing responsiveness in the pharmacy workforce

enthalten in: Research in social & administrative pharmacy : RSAP | 2023

von Forsyth, P. | Radley, A. | Rushworth, G. | +5

3

Are UK pharmacists ready for consultant-level practice? A cross-sectional survey of self-assessed development needs

enthalten in: The International journal of pharmacy practice | 2022

von Forsyth, P. | Radley, A. | Marra, F. | +10

4

Safe co-administration of direct-acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection : An international multicenter retrospective cohort study

enthalten in: Journal of viral hepatitis | 2022

von McDaniel, K. | Utz, A. | Akbashev, M. | +9

5

Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

enthalten in: Clinical pharmacology and therapeutics | 2022

von Marzolini, C. | Kuritzkes, D. | Marra, F. | +9

CommentIn: Clin Pharmacol Ther. 2023 Apr;113(4):768-769. - PMID 36544259

6

Prescribing Nirmatrelvir-Ritonavir : How to Recognize and Manage Drug-Drug Interactions

enthalten in: Annals of internal medicine | 2022

von Marzolini, C. | Kuritzkes, D. | Marra, F. | +9

7

Ritonavir and COVID-19 : pragmatic guidance is important

enthalten in: Lancet (London, England) | 2022

von Waters, L. | Marra, F. | Pozniak, A. | +2

CommentOn: Lancet. 2022 Jan 1;399(10319):21-22. - PMID 34973713

8

Fluvoxamine for the treatment of COVID-19

enthalten in: The Lancet. Global health | 2022

von Marzolini, C. | Marra, F. | Boyle, A. | +2

CommentOn: Lancet Glob Health. 2022 Jan;10(1):e42-e51. - PMID 34717820

9

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Marzolini, C. | Kuritzkes, D. | Marra, F. | +9

10

Safe co‐administration of direct‐acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection : An international multicenter retrospective cohort study

enthalten in: Journal of Viral Hepatitis | 2022

von McDaniel, K. | Utz, A. | Akbashev, M. | +9

1
2
3
4
5
Nächster »
[5]